EGFR targeting proved effective in vivo as a human tongue carcinoma xenograft mouse model showed increased tumoral uptake, enhanced PDT efficacy and prolonged anti-tumor effect of the EGFR targeted PS loaded micelles compared to untargeted micelles [282]. This evidence concerns the gene EGFR and tongue cancer.